Glucocorticoids acting through their specific receptor can either enhance o
r repress gene transcription. Dexamethasone represses interleukin-1 beta -s
timulated histone acetylation and granulocyte-macrophage colony-stimulating
factor expression through a combination of direct inhibition of p65-associ
ated histone acetyltransferase CHAT) activity and by recruiting histone dea
cetylase 2 (HDAC2) to the p65-HAT complex. Here we show that mifepristone,
a glucocorticoid receptor partial agonist, has no ability to induce gene ex
pression but represses interleukin-1 beta -stimulated histone acetylation a
nd granulocyte-macrophage colony-stimulating factor release by 50% maximall
y. Mifepristone was able to inhibit p65-associated HAT activity to the same
extent as dexamethasone but failed to inhibit the natural promoter to an e
qual extent clue to an inability to recruit HDAC2 to the p65-associated HAT
complex. These data suggest that the maximal repressive actions of glucoco
rticoids require recruitment of HDAC2 to a p65-HAT complex. These data also
suggest that pharmacological manipulation of specific histone acetylation
status is a potentially useful approach for the treatment of inflammatory d
iseases.